Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.99%1.5B | -1.95%3.26B | -3.05%1.51B | -7.33%3.32B | -14.28%1.56B | 23.71%3.59B | 45.82%1.82B | 6.40%2.9B | 1.79%1.25B | -25.34%2.72B |
| Operating income | -0.99%1.5B | -1.95%3.26B | -3.05%1.51B | -7.33%3.32B | -14.28%1.56B | 23.71%3.59B | 45.82%1.82B | 6.40%2.9B | 1.79%1.25B | -25.34%2.72B |
| Cost of sales | 1.05%-938.27M | 16.08%-1.93B | 18.32%-948.24M | 10.80%-2.3B | 8.48%-1.16B | -18.43%-2.58B | -35.56%-1.27B | -15.97%-2.18B | 3.08%-935.78M | 13.37%-1.88B |
| Operating expenses | 1.05%-938.27M | 16.08%-1.93B | 18.32%-948.24M | 10.80%-2.3B | 8.48%-1.16B | -18.43%-2.58B | -35.56%-1.27B | -15.97%-2.18B | 3.08%-935.78M | 13.37%-1.88B |
| Gross profit | -0.88%559.5M | 29.80%1.33B | 41.36%564.45M | 1.54%1.02B | -27.61%399.32M | 39.61%1.01B | 76.54%551.59M | -14.80%721.83M | 19.84%312.45M | -42.83%847.23M |
| Selling expenses | 7.39%-251.54M | 24.12%-539.1M | 16.10%-271.62M | 13.18%-710.43M | 3.44%-323.75M | -27.76%-818.26M | -12.11%-335.3M | -8.37%-640.46M | -3.35%-299.08M | 8.46%-591.02M |
| Administrative expenses | 6.13%-377.82M | 2.86%-809.87M | 9.07%-402.52M | 13.09%-833.74M | 12.77%-442.68M | -7.79%-959.34M | -40.21%-507.48M | -13.39%-889.98M | 7.53%-361.95M | 11.35%-784.87M |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | 214.75%856K | -115.61%-3.45M | -105.37%-746K | 3.76%22.1M |
| Impairment and provision | ---- | -85.78%-433.36M | -5.77%-44M | 1.69%-233.26M | -199.45%-41.6M | -185.58%-237.26M | -67.49%-13.89M | 36.65%-83.08M | 61.01%-8.29M | -494.23%-131.15M |
| -Goodwill impairment | ---- | -470.41%-93.86M | ---- | ---16.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -56.59%-339.51M | -5.77%-44M | 8.62%-216.81M | -199.45%-41.6M | -185.58%-237.26M | -67.49%-13.89M | 36.65%-83.08M | 61.01%-8.29M | -494.23%-131.15M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 57.10%-25.93M | -5.48%-106.37M | -50.10%-60.44M | 5.71%-100.85M |
| Special items of operating profit | -4.87%-1.96M | -204.93%-40.33M | 87.12%-1.87M | -1,307.76%-13.23M | -123.39%-14.51M | -99.55%1.1M | -29.51%62.03M | -40.93%240.86M | -15.90%88M | 66.63%407.77M |
| Operating profit | 53.83%-71.82M | 35.57%-494.41M | 63.25%-155.55M | 23.72%-767.37M | -57.85%-423.22M | -32.26%-1.01B | 18.77%-268.12M | -129.95%-760.65M | 9.10%-330.06M | -36.69%-330.79M |
| Financing income | -92.46%3.7M | ---- | --49.03M | ---- | ---- | --124.56M | ---- | ---- | ---- | ---- |
| Financing cost | 17.67%-61.18M | -0.48%-147.39M | -6.12%-74.3M | -80.88%-146.69M | ---70.02M | ---81.1M | ---- | ---- | ---- | ---- |
| Share of profits of associates | 380.73%923K | -180.95%-295K | -81.21%192K | -537.50%-105K | 323.14%1.02M | -98.52%24K | ---458K | 237.37%1.62M | ---- | -135.46%-1.18M |
| Share of profit from joint venture company | -44.44%15K | 33.33%48K | -51.79%27K | -81.82%36K | -88.64%56K | -31.72%198K | 16,533.33%493K | -62.77%290K | -100.35%-3K | 101.34%779K |
| Special items of earning before tax | ---- | 10.62%105.82M | ---- | --95.66M | 1,303.61%45.74M | ---- | ---3.8M | ---- | ---- | ---13.5M |
| Earning before tax | 28.93%-128.36M | 34.48%-536.23M | 59.54%-180.61M | 14.95%-818.47M | -64.20%-446.42M | -26.84%-962.36M | 17.63%-271.88M | -120.12%-758.74M | 8.88%-330.06M | -16.08%-344.69M |
| Tax | -8.76%-4.82M | 74.31%-5.06M | -6.44%-4.43M | -125.78%-19.7M | -117.21%-4.16M | -24.80%76.43M | -54.32%24.19M | 16.06%101.64M | -28.34%52.96M | 379.28%87.58M |
| After-tax profit from continuing operations | 28.03%-133.18M | 35.42%-541.3M | 58.93%-185.04M | 5.39%-838.17M | -81.91%-450.58M | -34.83%-885.94M | 10.61%-247.69M | -155.57%-657.1M | 3.90%-277.1M | 7.74%-257.11M |
| Earning after tax | 28.03%-133.18M | 35.42%-541.3M | 58.93%-185.04M | 5.39%-838.17M | -81.91%-450.58M | -34.83%-885.94M | 10.61%-247.69M | -155.57%-657.1M | 3.90%-277.1M | 7.74%-257.11M |
| Minority profit | 39.75%-25.05M | 33.34%-50.25M | 5.19%-41.58M | 4.35%-75.37M | -87.45%-43.86M | -660.57%-78.8M | -465.14%-23.4M | -143.58%-10.36M | 36.02%6.41M | 46.21%23.77M |
| Profit attributable to shareholders | 24.63%-108.12M | 35.63%-491.05M | 64.73%-143.46M | 5.49%-762.8M | -81.34%-406.72M | -24.80%-807.13M | 20.89%-224.29M | -130.25%-646.74M | 3.26%-283.51M | 4.76%-280.88M |
| Basic earnings per share | 30.30%-0.23 | 37.36%-1.09 | 64.52%-0.33 | 5.43%-1.74 | -82.35%-0.93 | -24.32%-1.84 | 21.54%-0.51 | -131.25%-1.48 | 2.99%-0.65 | 4.48%-0.64 |
| Diluted earnings per share | 30.30%-0.23 | 37.36%-1.09 | 64.52%-0.33 | 5.43%-1.74 | -82.35%-0.93 | -24.32%-1.84 | 21.54%-0.51 | -131.25%-1.48 | 2.99%-0.65 | 4.48%-0.64 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.